Savitz Ryan — SEC Form 4 filings
SEC reporting owner CIK 1992324. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-26 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 5 filings — 193,840 shares, $14,992,191 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 59,800 shares @ $83.90 ($5,017,220) in Dianthus Therapeutics, Inc. /DE/, filed 2026-04-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | 10 | — | 14 legs · 193,840 sh · $14,992,191 | 17 |
Form 4 filings — Savitz Ryan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 31,249 @ $21.77 · Sale (S): 10,354 @ $100.22 · Sale (S): 15,329 @ $101.24 · Sale (S): 5,566 @ $101.97 · Option exercise (M): 31,249 (derivative) @ $0 | EDGAR |
| 2026-04-10 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 8,224 @ $17.88 · Sale (S): 8,224 @ $89.84 · Option exercise (M): 8,224 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 74,367 @ $8.44 · Option exercise (M): 40,000 @ $17.88 · Sale (S): 1,390 @ $78.33 · Sale (S): 21,825 @ $78.86 · Sale (S): 1,485 @ $80.25 · Sale (S): 800 @ $81.36 · +6 more | EDGAR |
| 2026-02-04 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 20,000 @ $8.44 · Sale (S): 20,000 @ $45.18 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-09-25 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 20,000 @ $8.44 · Sale (S): 20,000 @ $35 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1992324 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →